Educational Content Only: Not medical advice. Always consult a qualified healthcare provider before using any compounds. Many peptides are research chemicals not approved by the FDA.

weight TrendingFDA Approved

Semaglutide

Also known as: Ozempic, Wegovy, Rybelsus

The gold standard GLP-1 — clinically proven weight loss and metabolic health

Method

injection

Level

beginner

Risk

high

Status

FDA Approved

Quick Summary

The gold standard GLP-1 — clinically proven weight loss and metabolic health

Also called: Ozempic, Wegovy, Rybelsus

What is Semaglutide?

Semaglutide is a GLP-1 (glucagon-like peptide-1) receptor agonist that has revolutionized the treatment of obesity and type 2 diabetes. Originally developed by Novo Nordisk as Ozempic for diabetes management, it gained widespread attention when approved as Wegovy for chronic weight management. Clinical trials demonstrated average weight loss of 15–17% of body weight, making it the most effective pharmaceutical weight loss treatment before the arrival of tirzepatide.

How It's Made

Semaglutide is a synthetic analog of the naturally occurring GLP-1 hormone, modified to resist degradation by the enzyme DPP-4. It has 94% sequence homology with human GLP-1 but with structural modifications including a C18 fatty acid chain that allows it to bind to albumin, extending its half-life to approximately 7 days.

Potential Benefits

15–17% average body weight reduction
Improved blood sugar control
Cardiovascular risk reduction
Reduced food cravings
Improved metabolic markers
Potential NASH/NAFLD improvement

Who Uses This?

Common goals and use cases for Semaglutide:

Obesity managementType 2 diabetesCardiovascular risk reductionMetabolic syndromeWeight-related health conditions

Where to Buy Semaglutide

Affiliate links — use code for discount. Always consult a healthcare provider before use.

Want a personalized protocol?

Take our AI-powered quiz to get a peptide protocol tailored to your specific goals and health profile.